YD Bio Limited Ordinary Shares (YDES)
YD Bio Limited Ordinary Shares operates in the Biotechnology industry of the Healthcare sector, headquartered in Taipei, TP, TW. The stock last traded at $2.65, down 16.93% on the session, giving a market capitalisation of $187.7M. On trailing twelve-month figures it carries a trailing P/E of -1.63, a net margin of 0.0%. Its beta of -0.12 implies it has historically moved less than the broad market.
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
YD Bio Limited Ordinary Shares is most often compared with the following Healthcare names: